Clinical trial
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
NCT00123630 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00123630 |
|---|---|
| Title | A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab |
| Official title | A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab |
| Lead sponsor | University of Utah, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophagitis |
| Intervention type | Drug |
| Interventions | omalizumab, Placebo |
| Enrollment | 30 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Jul 25, 2005 |
| Last update posted | May 20, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: